예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>유럽 척추 동종이식 및 이종이식 시장, 제품 유형별(동종이식, 이종이식, 뼈 이식 보충제), 접근 방식(전방 요추 추체간 융합술(ALIF), 경추간공 요추 추체간 융합술(TLIF), 후방 요추 추체간 융합술(PLIF), 수술 유형(개방 척추 수술 및 최소 침습 척추 수술), 적응증(퇴행성 질환, 척추 외상 또는 골절, 척추 종양, 교정 수술, 척추 감염(골수염 또는 디스크염), 척추 기형, 선천적 척추 이상 및 기타), 연령대(성인, 노인 및 소아), 최종 사용자(병원, 전문 클리닉, 외래 수술 센터 및 기타) - 업계 동향 및 2030년까지의 예측.
유럽 척추 이식편 및 이종이식편 시장 분석 및 규모
유럽은 고령 인구가 상당히 많고, 퇴행성 디스크 질환 및 척추 골절과 같은 척추 질환은 나이가 들면서 더 흔해지고 있습니다. 고령 인구가 증가함에 따라 척추 수술 및 이식에 대한 수요가 증가하여 시장 성장을 촉진합니다. 퇴행성 디스크 질환, 척추 협착증 및 척추 골절을 포함한 척추 장애는 유럽에서 비교적 흔합니다. 이러한 질환은 종종 수술적 치료의 일부로 척추 이식이 필요하여 시장 성장에 기여합니다. 최소 침습적 시술 및 로봇 보조 수술과 같은 척추 수술 기술의 발전으로 이러한 혁신적인 접근 방식을 지원할 수 있는 이식 재료에 대한 수요가 증가했습니다.
Data Bridge Market Research는 유럽 척추 이식편 및 이종이식편 시장이 2030년까지 6억 6,939만 달러에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 5.6%라고 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
제품 유형( 이종이식 , 이종이식, 골 이식 보충제), 접근 방식(전방 요추 추체간 융합술(ALIF), 경추간공 요추 추체간 융합술(TLIF), 후방 요추 추체간 융합술(PLIF), 수술 유형(개방 척추 수술 및 최소 침습 척추 수술), 적응증(퇴행성 질환, 척추 외상 또는 골절, 척추 종양, 재수술, 척추 감염 (골수염 또는 디스크염), 척추 기형, 선천적 척추 이상 및 기타), 연령대(성인, 노인 및 소아), 최종 사용자(병원, 전문 병원, 외래 수술 센터 및 기타) |
|
적용 국가 |
독일, 프랑스, 영국, 이탈리아, 스페인, 러시아, 스위스, 네덜란드, 터키, 폴란드, 스웨덴, 벨기에, 덴마크, 핀란드, 노르웨이 및 기타 유럽 국가 |
|
시장 참여자 포함 |
Medtronic, Arthrex, Inc., Stryker, ZimVie Inc., Medical Devices Business Services, Inc., RTI Surgical, Integra LifeSciences, Orthofix US LLC., ATEC Spine, Inc., Globus Medical, Exactech, Inc., Regenity, Cerapedics.Inc, Bioventus 등 |
시장 정의
척추 이식편 은 척추 수술에 사용되는 생물학적 이식 재료입니다. 일반적으로 시체인 인간 기증자로부터 채취하여 세포와 항원을 제거하여 이식 거부 및 질병 전파 위험을 줄입니다. 처리된 이식편 뼈는 척추 융합 수술과 같은 척추 시술에서 뼈 성장과 융합을 촉진하여 다양한 척추 상태를 치료하는 데 사용됩니다. 척추 이종이식편은 척추 수술에 사용되는 이식 재료로, 일반적으로 소(소 이종이식) 또는 돼지(돼지 이종이식)와 같은 동물인 비인간 종에서 공급됩니다. 이종이식편은 면역 거부 및 질병 전파 위험을 줄이기 위해 처리됩니다. 적합한 인간 기증자가 없거나 외과의와 환자가 비인간 뼈 공급원을 선호할 때 척추 수술에서 인간 이식편의 대안으로 사용됩니다. 유럽 척추 이식편 및 이종이식 시장은 척추와 관련된 수술 절차를 위한 척추 이식편 및 이종이식 재료의 생산, 유통, 활용을 포함하는 의료 산업 부문을 말합니다.
유럽 척추 이식편 및 이종이식편 시장 동향
이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 척추 질환의 증가 발생률
척추 장애는 척추, 척수 및 관련 구조에 영향을 미치는 광범위한 상태를 포함합니다. 여러 요인이 척추 장애의 발생률 증가에 기여하고, 결과적으로 척추 이식 재료에 대한 수요를 증가시킵니다. 장시간 앉아 있고, 신체 활동이 감소하고, 자세가 나쁜 현대적 라이프스타일은 척추 장애의 발병에 기여할 수 있습니다. 이러한 요인은 척추 구조의 마모를 가속화하고 탈장 디스크 및 요추 변성과 같은 상태의 위험을 증가시킬 수 있습니다. 자동차 사고, 낙상 및 스포츠 관련 부상과 같은 외상성 부상은 척추 골절, 탈구 및 기타 심각한 척추 장애를 초래할 수 있습니다. 이러한 부상은 종종 수술적 개입과 척추 재건을 위한 이식 재료의 사용을 필요로 합니다.
- 척추 이식에 사용되는 수술 기술의 발전
척추 수술에 로봇을 통합함으로써 수술의 정밀도, 정확도, 결과가 향상되었습니다. 외과의는 더욱 자신 있게 복잡한 시술을 수행할 수 있습니다. 로봇 보조 수술에는 종종 로봇 시스템과 함께 사용할 수 있는 고급 이식 재료가 필요합니다. 이는 로봇 수술과 호환되는 이식 재료에 대한 필요성을 촉진하여 시장 확장에 기여합니다. 내비게이션 시스템과 수술 중 영상 도구는 외과의가 척추 수술을 보다 효과적으로 계획하고 실행하는 데 도움이 됩니다. 정밀한 내비게이션은 외과의가 이식 재료의 최적 배치를 결정하여 척추 융합 및 안정성을 촉진하는 효과를 높이는 데 도움이 됩니다. 조직 공학 및 재생 의학의 발전으로 생체 적합성과 융합 특성이 향상된 이식 재료를 개발할 수 있는 새로운 가능성이 열렸습니다. 조직 공학 구조 및 생물학적으로 활성인 이식과 같은 혁신적인 이식 재료의 등장은 척추 외과의와 환자에게 향상된 옵션을 제공하며, 이는 시장 성장을 촉진할 것으로 예상됩니다.
기회
- 환자들 사이에서 이식의 이점에 대한 인식이 높아지다
환자들은 이식 기반 수술적 개입을 고려하는 데 점점 더 개방적이 되고 있습니다. 정보에 입각한 환자는 의료 결정 과정에 적극적으로 참여할 가능성이 더 큽니다. 이종이식과 이종이식의 이점을 이해하는 환자는 이러한 재료를 포함하는 수술적 시술에 더 수용적일 수 있으며, 이로 인해 이식 기반 수술에 대한 수요가 증가합니다. 환자들은 더 나은 결과, 빠른 회복, 통증 감소를 제공하는 치료법을 점점 더 많이 찾고 있습니다. 이식 재료는 척추 융합 및 정형학적 안정화를 달성하는 데 필수적이며, 이는 환자의 결과를 개선할 수 있습니다. 환자들은 이러한 이점을 얻기 위해 이식 기반 수술을 요청할 가능성이 더 큽니다. 환자들은 종종 수술 후 통증을 줄이고 더 빨리 회복하는 시술을 선택하도록 동기를 부여받습니다. 이식 재료는 척추 융합 및 안정화에 중요한 역할을 하며, 회복 시간을 단축하고 통증을 줄이는 데 기여합니다. 이러한 이점에 대한 환자의 선호도는 이식 기반 시술에 대한 수요를 촉진할 수 있습니다.
척추 및 정형외과 수술에서 이식편의 이점에 대한 환자의 인식이 높아지면서 시장 성장의 기회가 창출되고 있습니다. 이러한 이점에 대해 잘 알고 있는 환자는 이식편 기반 수술적 개입을 고려할 가능성이 더 높으며, 이로 인해 이식편 재료 및 시술에 대한 수요가 증가합니다.
제지 / 도전
- 척추 이식과 관련된 합병증 위험
이러한 이식 재료는 척추 융합과 안정성을 달성하는 데 필수적이지만, 사용과 관련된 합병증은 환자와 의료 서비스 제공자 모두에게 영향을 미칠 수 있습니다. 어떤 경우에는 수혜자의 면역 체계가 이식 재료를 이물질 조직으로 인식하고 면역 반응을 일으켜 이식 거부 반응을 일으킬 수 있습니다. 이식 거부의 위험으로 인해 외과의와 환자는 이종이식과 이종이식을 사용하지 않아 합성 또는 자가 이식 옵션을 선호하게 됩니다. 감염은 척추 수술을 포함한 모든 수술 절차의 잠재적인 합병증입니다. 이식 재료는 감염이 발생할 수 있는 부위 역할을 할 수 있습니다. 수술 후 감염의 위험으로 인해 의료 서비스 제공자와 환자는 이식 재료 사용에 신중해져 시장 성장에 영향을 미칠 수 있습니다. 이식 통합과 관련된 합병증이나 문제로 인해 척추 융합이 지연되거나 실패하여 추가 수술이 필요할 수 있습니다. 외과의와 환자는 융합이 지연될 가능성에 대해 우려하여 이식 재료 선택에 신중을 기하게 될 수 있습니다.
의료 서비스 제공자는 척추 이종이식 및 이종이식과 관련된 합병증을 최소화하기 위해 환자 평가, 수술 전 계획 및 수술 후 관리를 우선시하여 이러한 위험을 해결합니다. 또한, 지속적인 R&D 노력은 환자의 안전과 결과를 향상시키기 위해 이식 재료와 수술 기술을 개선하는 데 중점을 둡니다.
따라서 척추 이식과 관련된 합병증의 위험이 시장 성장을 제한할 것으로 예상됩니다.
유럽 척추 이식편 및 이종이식편 시장 범위
유럽 척추 이식편 및 이종이식편 시장은 제품 유형, 접근 방식, 수술 유형, 적응증, 연령대 및 최종 사용자를 기준으로 6개의 주요 세그먼트로 세분화됩니다. 이러한 세그먼트의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
제품 유형
- 이종이식
- 이종 이식
- 뼈 이식 보충제
제품 유형을 기준으로 유럽 척추 이식편 및 이종이식편 시장은 동종이식편, 이종이식편, 뼈 이식 보충제로 구분됩니다.
구혼
- 전방 요추 척추간 융합술 (ALIF)
- 경추간 요추체간 융합술(TLIF)
- 후방 요추 척추간 융합술(PLIF)
접근 방식을 기준으로, 유럽 척추 이종이식 및 이종이식 시장은 전방 요추 추체간 융합술(ALIF), 경추간공 요추 추체간 융합술(TLIF), 후방 요추 추체간 융합술(PLIF)로 구분됩니다.
수술 유형
- 개방형 척추 수술
- 최소 침습 척추 수술
수술 유형을 기준으로 볼 때, 유럽 척추 이종이식 및 이종이식 시장은 개방형 척추 수술과 최소 침습 척추 수술로 구분됩니다.
표시
- 퇴행성 질환
- 척추 외상 또는 골절
- 척추 종양
- 수정 수술
- 척추 감염( 골수염 또는 디스크염)
- 척추 변형
- 선천성 척추 이상
- 기타
유럽 척추 이종이식 및 이종이식 시장은 적응증을 기준으로 퇴행성 질환, 척추 외상이나 골절, 척추 종양, 교정 수술, 척추 감염(골수염이나 디스크염), 척추 기형, 선천적 척추 이상 및 기타로 구분됩니다.
연령대
- 성인
- 노인
- 소아과
유럽 척추 이식편 및 이종이식편 시장은 연령대를 기준으로 성인, 노인, 소아로 구분됩니다.
최종 사용자
- 병원
- 전문 클리닉
- 외래 수술 센터
- 기타
유럽 척추 이식편 및 이종이식편 시장은 최종 사용자를 기준으로 병원, 전문 진료소, 외래 수술 센터 및 기타로 구분됩니다.
유럽 척추 이식편 및 이종이식편 시장 지역 분석/통찰력
유럽 척추 이식편 및 이종이식편 시장은 제품 유형, 접근 방식, 수술 유형, 적응증, 연령대 및 최종 사용자를 기준으로 6개의 주요 세그먼트로 구분됩니다.
이 시장 보고서에서 다루는 국가는 독일, 프랑스, 영국, 이탈리아, 스페인, 러시아, 스위스, 네덜란드, 터키, 폴란드, 스웨덴, 벨기에, 덴마크, 핀란드, 노르웨이 및 기타 유럽 국가입니다.
척추 이식에 대한 수요가 증가함에 따라 독일이 가장 큰 시장 점유율을 차지하며 시장을 장악할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터의 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 척추 이식편 및 이종이식편 시장 점유율 분석
유럽 척추 이식편 및 이종이식편 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
유럽 척추 이식편 및 이종이식편 시장의 주요 참여자로는 Medtronic, Arthrex, Inc., Stryker, ZimVie Inc., Medical Devices Business Services, Inc., RTI Surgical, Integra LifeSciences, Orthofix US LLC., ATEC Spine, Inc., Globus Medical, Exactech, Inc., Regenity, Cerapedics.Inc, Bioventus 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 MARKET DATA ON PRE-IMPLANT SURGERIES, BY COUNTRY
5 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: REGULATIONS
5.1 REGULATION IN EUROPE
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF SPINAL DISORDERS
6.1.2 ADVANCEMENTS IN SURGICAL TECHNIQUES USED IN SPINAL GRAFT
6.1.3 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
6.2 RESTRAINTS
6.2.1 RISK OF COMPLICATIONS RELATED TO SPINAL GRAFT
6.2.2 REGULATORY CHALLENGES FOR THE APPROVAL OF NEW GRAFT MATERIALS
6.3 OPPORTUNITIES
6.3.1 RISING AWARENESS AMONG PATIENTS ABOUT THE BENEFITS OF GRAFTS
6.3.2 ADVANCEMENTS IN REGENERATIVE MEDICINES
6.4 CHALLENGES
6.4.1 ETHICAL AND SAFETY CONCERNS REGARDING ALLOGRAFT AND XENOGRAFT
6.4.2 HIGH COST ASSOCIATED WITH SPINAL GRAFT PROCEDURES
7 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 ALLOGRAFT
7.2.1 TYPE
7.2.1.1 CANCELLOUS ALLOGRAFT
7.2.1.2 CORTICAL ALLOGRAFT
7.2.1.3 DEMINERALIZED BONE MATRIX
7.2.1.4 OTHERS
7.2.2 INDICATION
7.2.2.1 DEGENERATIVE DISEASES
7.2.2.2 SPINAL TRAUMA OR FRACTURES
7.2.2.3 SPINAL TUMORS
7.2.2.4 REVISION SURGERIES
7.2.2.5 SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS)
7.2.2.6 SPINAL DEFORMITIES
7.2.2.7 CONGENITAL SPINAL ABNORMALITIES
7.2.2.8 OTHERS
7.2.3 STORAGE
7.2.3.1 FROZEN (LESS THAN 0°C)
7.2.3.2 REFRIGERATED (0°C TO 10°C)
7.3 XENOGRAFT
7.3.1 TYPE
7.3.2 BOVINE
7.3.3 EQUINE
7.3.4 OTHERS
7.3.5 INDICATION
7.3.5.1 DEGENERATIVE DISEASES
7.3.5.2 SPINAL TRAUMA OR FRACTURES
7.3.5.3 SPINAL TUMORS
7.3.5.4 REVISION SURGERIES
7.3.5.5 SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS)
7.3.5.6 SPINAL DEFORMITIES
7.3.5.7 CONGENITAL SPINAL ABNORMALITIES
7.3.5.8 OTHERS
7.4 BONE GRAFT SUPPLEMENTS
7.4.1 MESENCHYMAL STEM CELLS (MSCS)
7.4.2 OSTEOGENIC CELLS
7.4.3 GROWTH FACTORS
7.4.4 BONE MORPHOGENETIC PROTEINS (BMPS)
8 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES
8.1 OVERVIEW
8.2 ANTERIOR LUMBAR INTERBODY FUSION (ALIF)
8.3 TRANSFORAMINAL LUMBAR INTERBODY FUSION (TLIF)
8.4 POSTERIOR LUMBAR INTERBODY FUSION (PLIF)
9 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE
9.1 OVERVIEW
9.2 OPEN SPINE SURGERY
9.2.1 PRODUCT TYPE
9.2.1.1 ALLOGRAFT
9.2.1.2 XENOGRAFT
9.2.2 INDICATION
9.2.2.1 DEGENERATIVE DISEASES
9.2.2.2 SPINAL TRAUMA OR FRACTURES
9.2.2.3 SPINAL TUMORS
9.2.2.4 REVISION SURGERIES
9.2.2.5 SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS)
9.2.2.6 SPINAL DEFORMITIES
9.2.2.7 CONGENITAL SPINAL ABNORMALITIES
9.2.2.8 OTHERS
9.3 MINIMALLY INVASIVE SPINE SURGERY
9.3.1 PRODUCT TYPE
9.3.1.1 ALLOGRAFT
9.3.1.2 XENOGRAFT
9.3.2 INDICATION
9.3.2.1 DEGENERATIVE DISEASES
9.3.2.2 SPINAL TRAUMA OR FRACTURES
9.3.2.3 SPINAL TUMORS
9.3.2.4 REVISION SURGERIES
9.3.2.5 SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS)
9.3.2.6 SPINAL DEFORMITIES
9.3.2.7 CONGENITAL SPINAL ABNORMALITIES
9.3.2.8 OTHERS
10 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION
10.1 OVERVIEW
10.2 DEGENERATIVE DISEASES
10.2.1 ALLOGRAFT
10.2.2 XENOGRAFT
10.3 SPINAL TRAUMA OR FRACTURES
10.3.1 ALLOGRAFT
10.3.2 XENOGRAFT
10.4 SPINAL TUMORS
10.4.1 ALLOGRAFT
10.4.2 XENOGRAFT
10.5 REVISION SURGERIES
10.5.1 ALLOGRAFT
10.5.2 XENOGRAFT
10.6 SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS)
10.6.1 ALLOGRAFT
10.6.2 XENOGRAFT
10.7 SPINAL DEFORMITIES
10.7.1 ALLOGRAFT
10.7.2 XENOGRAFT
10.8 CONGENITAL SPINAL ABNORMALITIES
10.8.1 ALLOGRAFT
10.8.2 XENOGRAFT
10.9 OTHERS
11 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 GERIATRIC
11.4 PEDIATRIC
12 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 TYPE
12.2.1.1 PUBLIC
12.2.1.2 PRIVATE
12.2.2 TIER
12.2.2.1 TIER 1
12.2.2.2 TIER 2
12.2.2.3 TIER 3
12.3 SPECIALTY CLINIC
12.4 AMBULATORY SURGICAL CENTERS
12.5 OTHERS
13 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 FRANCE
13.1.3 U.K.
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 SWITZERLAND
13.1.8 NETHERLANDS
13.1.9 TURKEY
13.1.10 POLAND
13.1.11 SWEDEN
13.1.12 BELGIUM
13.1.13 DENMARK
13.1.14 FINLAND
13.1.15 NORWAY
13.1.16 REST OF EUROPE
14 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 MEDTRONIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 ARTHREX, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 PRODUCT PORTFOLIO
16.2.3 RECENT DEVELOPMENT
16.3 STRYKER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENT
16.4 ZIMVIE INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 EVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 MEDICAL DEVICES BUSINESS SERVICES, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 RECENT DEVELOPMENT
16.6 ATEC SPINE, INC
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 BIOVENTUS
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 CERAPEDICS.INC
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 EXACTECH, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 GLOBUS MEDICAL
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 INTEGRA LIFESCIENCES
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 ORTHOFIX US LLC.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 REGENITY
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 RTI SURGICAL
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 MARKET DATA OF MAXILLOFACIAL SURGERIES
TABLE 2 MARKET DATA OF ORTHOPEDIC SURGERIES
TABLE 3 MARKET DATA OF NUMBER OF DENTAL SURGERIES
TABLE 4 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 EUROPE ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 7 EUROPE ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION))
TABLE 11 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 12 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE , 2021-2030 (USD MILLION )
TABLE 13 EUROPE OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 EUROPE OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 EUROPE MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 EUROPE SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 EUROPE SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 EUROPE CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 26 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 EUROPE HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 28 EUROPE HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 29 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 30 GERMANY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 GERMANY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 GERMANY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 33 GERMANY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 34 GERMANY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 GERMANY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 36 GERMANY BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 GERMANY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 38 GERMANY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 39 GERMANY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 GERMANY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 41 GERMANY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 GERMANY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 43 GERMANY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 44 GERMANY DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 GERMANY SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 46 GERMANY SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 GERMANY REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 GERMANY SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 GERMANY SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 GERMANY CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 GERMANY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 52 GERMANY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 GERMANY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 GERMANY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 55 FRANCE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 FRANCE ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 57 FRANCE ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 58 FRANCE ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 59 FRANCE XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 60 FRANCE XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 61 FRANCE BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 62 FRANCE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 63 FRANCE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 64 FRANCE OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 FRANCE OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 66 FRANCE MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 FRANCE MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 68 FRANCE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 69 FRANCE DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 FRANCE SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 FRANCE SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 72 FRANCE REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 FRANCE SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 FRANCE SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 75 FRANCE CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 FRANCE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP , 2021-2030 (USD MILLION)
TABLE 77 FRANCE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER , 2021-2030 (USD MILLION)
TABLE 78 FRANCE HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 FRANCE HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 80 U.K. SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 U.K. ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 U.K. ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 83 U.K. ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 84 U.K. XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 85 U.K. XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 86 U.K. BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 87 U.K. SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 88 U.K. SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.K. OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 U.K. OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 91 U.K. MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.K. MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 93 U.K. SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 94 U.K. DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.K. SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.K. SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 U.K. REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.K. SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.K. SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.K. CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.K. SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP , 2021-2030 (USD MILLION)
TABLE 102 U.K. SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 103 U.K. HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.K. HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 105 ITALY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 106 ITALY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 ITALY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 108 ITALY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 109 ITALY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 110 ITALY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 111 ITALY BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 112 ITALY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 113 ITALY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 114 ITALY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 ITALY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 116 ITALY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 ITALY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 118 ITALY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 119 ITALY DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 ITALY SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 ITALY SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 ITALY REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 ITALY SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 ITALY SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 ITALY CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 ITALY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 127 ITALY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER , 2021-2030 (USD MILLION)
TABLE 128 ITALY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 ITALY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 130 SPAIN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 SPAIN ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 SPAIN ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 133 SPAIN ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 134 SPAIN XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 135 SPAIN XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 136 SPAIN BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 137 SPAIN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 138 SPAIN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 139 SPAIN OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 SPAIN OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 141 SPAIN MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 SPAIN MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 143 SPAIN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 144 SPAIN DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 SPAIN SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 SPAIN SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 147 SPAIN REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 SPAIN SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 SPAIN SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 SPAIN CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 SPAIN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP , 2021-2030 (USD MILLION)
TABLE 152 SPAIN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER , 2021-2030 (USD MILLION)
TABLE 153 SPAIN HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SPAIN HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 155 RUSSIA SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 RUSSIA ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 157 RUSSIA ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 158 RUSSIA ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 159 RUSSIA XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 160 RUSSIA XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 161 RUSSIA BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 162 RUSSIA SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 163 RUSSIA SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 164 RUSSIA OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 RUSSIA OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 166 RUSSIA MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 RUSSIA MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 168 RUSSIA SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 169 RUSSIA DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 RUSSIA SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 171 RUSSIA SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 RUSSIA REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 RUSSIA SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 174 RUSSIA SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 RUSSIA CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 RUSSIA SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 177 RUSSIA SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 178 RUSSIA HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 RUSSIA HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 180 SWITZERLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 SWITZERLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 SWITZERLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 183 SWITZERLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 184 SWITZERLAND XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 185 SWITZERLAND XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 186 SWITZERLAND BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 187 SWITZERLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 188 SWITZERLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 189 SWITZERLAND OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 SWITZERLAND OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 191 SWITZERLAND MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 192 SWITZERLAND MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 193 SWITZERLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 194 SWITZERLAND DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 SWITZERLAND SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 SWITZERLAND SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 SWITZERLAND REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 SWITZERLAND SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 SWITZERLAND SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 SWITZERLAND CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 SWITZERLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP , 2021-2030 (USD MILLION)
TABLE 202 SWITZERLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 203 SWITZERLAND HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 204 SWITZERLAND HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 205 NETHERLANDS SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 206 NETHERLANDS ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 207 NETHERLANDS ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 208 NETHERLANDS ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 209 NETHERLANDS XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 210 NETHERLANDS XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 211 NETHERLANDS BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 212 NETHERLANDS SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES , 2021-2030 (USD MILLION)
TABLE 213 NETHERLANDS SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 214 NETHERLANDS OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 NETHERLANDS OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 216 NETHERLANDS MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 NETHERLANDS MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 218 NETHERLANDS SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 219 NETHERLANDS DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 NETHERLANDS SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 NETHERLANDS SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 NETHERLANDS REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 223 NETHERLANDS SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 NETHERLANDS SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 225 NETHERLANDS CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 226 NETHERLANDS SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 227 NETHERLANDS SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 228 NETHERLANDS HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 229 NETHERLANDS HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 230 TURKEY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 231 TURKEY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 232 TURKEY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 233 TURKEY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 234 TURKEY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 235 TURKEY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 236 TURKEY BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 237 TURKEY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES , 2021-2030 (USD MILLION)
TABLE 238 TURKEY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 239 TURKEY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 TURKEY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 241 TURKEY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 TURKEY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 243 TURKEY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 244 TURKEY DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 245 TURKEY SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 TURKEY SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 247 TURKEY REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 248 TURKEY SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 TURKEY SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 250 TURKEY CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 251 TURKEY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 252 TURKEY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 TURKEY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 TURKEY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 255 POLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 POLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 257 POLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 258 POLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 259 POLAND XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 260 POLAND XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 261 POLAND BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 262 POLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 263 POLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 264 POLAND OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 POLAND OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 266 POLAND MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 267 POLAND MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 268 POLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 269 POLAND DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 POLAND SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 POLAND SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 POLAND REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 273 POLAND SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 POLAND SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 275 POLAND CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 276 POLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 277 POLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 POLAND HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 279 POLAND HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 280 SWEDEN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 SWEDEN ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 282 SWEDEN ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 283 SWEDEN ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 284 SWEDEN XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 285 SWEDEN XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 286 SWEDEN BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 SWEDEN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 288 SWEDEN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 289 SWEDEN OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 290 SWEDEN OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 291 SWEDEN MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 292 SWEDEN MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 293 SWEDEN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 294 SWEDEN DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 295 SWEDEN SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 SWEDEN SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 297 SWEDEN REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 298 SWEDEN SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 299 SWEDEN SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 300 SWEDEN CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 301 SWEDEN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP , 2021-2030 (USD MILLION)
TABLE 302 SWEDEN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER , 2021-2030 (USD MILLION)
TABLE 303 SWEDEN HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 304 SWEDEN HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 305 BELGIUM SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 306 BELGIUM ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 307 BELGIUM ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 308 BELGIUM ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE , 2021-2030 (USD MILLION)
TABLE 309 BELGIUM XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 310 BELGIUM XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 311 BELGIUM BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 312 BELGIUM SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 313 BELGIUM SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 314 BELGIUM OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 315 BELGIUM OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 316 BELGIUM MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 317 BELGIUM MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 318 BELGIUM SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 319 BELGIUM DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 320 BELGIUM SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 321 BELGIUM SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 322 BELGIUM REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 323 BELGIUM SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 324 BELGIUM SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 BELGIUM CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 326 BELGIUM SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 327 BELGIUM SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 328 BELGIUM HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 329 BELGIUM HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 330 DENMARK SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 331 DENMARK ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 332 DENMARK ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 333 DENMARK ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 334 DENMARK XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 335 DENMARK XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 336 DENMARK BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 337 DENMARK SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 338 DENMARK SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 339 DENMARK OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 DENMARK OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 341 DENMARK MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 342 DENMARK MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 343 DENMARK SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 344 DENMARK DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 345 DENMARK SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 346 DENMARK SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 347 DENMARK REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 348 DENMARK SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 349 DENMARK SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 350 DENMARK CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 351 DENMARK SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 352 DENMARK SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 353 DENMARK HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 354 DENMARK HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 355 FINLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 356 FINLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 357 FINLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 358 FINLAND ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 359 FINLAND XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 360 FINLAND XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 361 FINLAND BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 362 FINLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 363 FINLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 364 FINLAND OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 365 FINLAND OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 366 FINLAND MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 367 FINLAND MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 368 FINLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 369 FINLAND DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 370 FINLAND SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 371 FINLAND SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 372 FINLAND REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 373 FINLAND SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 374 FINLAND SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 375 FINLAND CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 376 FINLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 377 FINLAND SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 378 FINLAND HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 379 FINLAND HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 380 NORWAY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 381 NORWAY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 382 NORWAY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 383 NORWAY ALLOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY STORAGE, 2021-2030 (USD MILLION)
TABLE 384 NORWAY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 385 NORWAY XENOGRAFTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 386 NORWAY BONE GRAFT SUPPLEMENTS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 387 NORWAY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY APPROACHES, 2021-2030 (USD MILLION)
TABLE 388 NORWAY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 389 NORWAY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 390 NORWAY OPEN SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 391 NORWAY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 392 NORWAY MINIMALLY INVASIVE SPINE SURGERY IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 393 NORWAY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY INDICATION, 2021-2030 (USD MILLION)
TABLE 394 NORWAY DEGENERATIVE DISEASES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 395 NORWAY SPINAL TRAUMA OR FRACTURES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 NORWAY SPINAL TUMORS IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 NORWAY REVISION SURGERIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 398 NORWAY SPINAL INFECTIONS (OSTEOMYELITIS OR DISCITIS) IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 399 NORWAY SPINAL DEFORMITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 NORWAY CONGENITAL SPINAL ABNORMALITIES IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 401 NORWAY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY AGE GROUP , 2021-2030 (USD MILLION)
TABLE 402 NORWAY SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 403 NORWAY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 404 NORWAY HOSPITAL IN SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 405 REST OF EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: SEGMENTATION
FIGURE 2 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: SEGMENTATION
FIGURE 11 THE RISING INCIDENCE OF SPINAL DISORDERS IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET FROM 2023 TO 2030
FIGURE 12 THE ALLOGRAFT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET
FIGURE 14 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: BY APPROACHES, 2022
FIGURE 16 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: BY SURGERY TYPE, 2022
FIGURE 17 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: BY INDICATION, 2022
FIGURE 18 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: BY AGE GROUP, 2022
FIGURE 19 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: BY END USER, 2022
FIGURE 20 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: SNAPSHOT (2022)
FIGURE 21 EUROPE SPINAL ALLOGRAFTS AND XENOGRAFT MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
